Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_3
1
20%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

unknown120%
withdrawn120%
completed240%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_3

Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients.

NCT07319208
unknownnot_applicable

Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure

NCT05298098
completedphase_2

Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites

NCT04785755
withdrawn

Coagulation Activation by Hyperosmolar Agents in Intracranial Hypertension

NCT03409237
completednot_applicable

Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis

NCT02392663

Clinical Trials (5)

Showing 5 of 5 trials
NCT07319208Phase 3

Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients.

Recruiting
NCT05298098Not Applicable

Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure

Unknown
NCT04785755Phase 2

Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites

Completed
NCT03409237

Coagulation Activation by Hyperosmolar Agents in Intracranial Hypertension

Withdrawn
NCT02392663Not Applicable

Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5